These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4756175)

  • 1. [L-dopa in 122 cases of Parkinson's disease in patients over 70 years old. Comparative study with a group of Parkinsonian patients who are 41 to 69 years old].
    Vignalou J; Beck H
    Gerontol Clin (Basel); 1973; 15(1):50-64. PubMed ID: 4756175
    [No Abstract]   [Full Text] [Related]  

  • 2. A year's experience of L-DOPA in the treatment of Parkinson's disease.
    Guidetti B; Giuffrè R
    Acta Neurochir (Wien); 1971; 24(2):81-8. PubMed ID: 5112463
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of L-dopa in Parkinson's disease.
    Godwin-Austen RB; Tomlinson EB; Frears CC; Kok HW
    Lancet; 1969 Jul; 2(7613):165-8. PubMed ID: 4183130
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical analyses of factors influencing L-dopa treatment of Parkinson's syndrome.
    Granerus AK; Steg G; Svanborg A
    Acta Med Scand; 1972; 192(1-2):1-11. PubMed ID: 4559530
    [No Abstract]   [Full Text] [Related]  

  • 5. [L-Dopa in the treatment of Parkinson's disease. (Considerations on 51 cases)].
    Mazza C; Buffatti PF; Bazzan A; Lion P
    Fracastoro; 1970; 63(5):768-73. PubMed ID: 5519378
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report.
    Wycis HT
    Confin Neurol; 1972; 34(2):130-5. PubMed ID: 4666056
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of Parkinson's disease with L-dopa. 77 cases].
    Boudin G; Castaigne P; Lhermitte F; Beck H; Guillard A; Marteau R; Pepin B; Rondot P; Raphy B
    Rev Neurol (Paris); 1970 Feb; 122(2):89-102. PubMed ID: 4931719
    [No Abstract]   [Full Text] [Related]  

  • 8. [L-dopa effect in Parkinson's syndrome].
    Römer F; Bettag W; Bock WJ
    Z Allgemeinmed; 1971 Feb; 47(6):281-3. PubMed ID: 5571715
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical study of L-dopa in Parkinson's disease].
    Franken L; Noel G; Lhoas JP; Meyers C; Noel P; Ectors M
    Brux Med; 1972 Dec; 52(12):851-60. PubMed ID: 4575350
    [No Abstract]   [Full Text] [Related]  

  • 10. L-dopa in the treatment of Parkinsonism; a preliminary appraisal.
    Stellar S; Mandell S; Waltz JM; Cooper IS
    J Neurosurg; 1970 Mar; 32(3):275-80. PubMed ID: 5416909
    [No Abstract]   [Full Text] [Related]  

  • 11. L-dopa therapy in Parkinson's disease.
    Lipman IJ
    Va Med Mon (1918); 1971 May; 98(5):242-8. PubMed ID: 4931138
    [No Abstract]   [Full Text] [Related]  

  • 12. Failures of L-dopa.
    Paulson GW
    Ohio State Med J; 1973 Dec; 69(12):896-8. PubMed ID: 4769406
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative measurements of L-dopa therapy in Parkinson's disease.
    Webster DD
    Trans Am Neurol Assoc; 1969; 94():348-50. PubMed ID: 5374483
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of Parkinson's disease with L-dopa: a current appraisal.
    Kofman O
    Can Med Assoc J; 1971 Mar; 104(6):483-7. PubMed ID: 5549988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Parkinson's syndrome with L-DOPA on an out-patient basis.
    Fehling C
    Z Neurol; 1972; 202(3):197-208. PubMed ID: 4120049
    [No Abstract]   [Full Text] [Related]  

  • 16. Observations on patients with Parkinson's disease treated with L-dopa. I. Trial and evaluation of L-dopa therapy.
    van Wieringen A; Wright J
    S Afr Med J; 1972 Sep; 46(35):1262-6. PubMed ID: 4638222
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy and side effects of L-dopa in patients with Parkinson's syndrome].
    Lombardo L
    Arch Invest Med (Mex); 1973; 4(3):215-24. PubMed ID: 4784173
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug therapy of Parkinson's syndrome. Clinical long-term study using L-dopa and the drug conbination L-dopa-decarboxylase inhibitor].
    Christiani K; Möller WD
    Munch Med Wochenschr; 1973 Apr; 115(16):711-3. PubMed ID: 4197759
    [No Abstract]   [Full Text] [Related]  

  • 19. A double blind study of 1-dopa treatment in Parkinson's disease.
    Rinne UK; Sonninen V
    Eur Neurol; 1968; 1(3):180-91. PubMed ID: 4880674
    [No Abstract]   [Full Text] [Related]  

  • 20. [L-dopa treatment of parkinsonism].
    Szulc-Kuberska J; Niewodniczy A; Poźniak-Patewicz E; Wolczyk-Orzechowska M
    Neurol Neurochir Pol; 1973; 7(1):63-8. PubMed ID: 4511385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.